polyomaviru
jc
jcv
infect
caus
fatal
human
demyelin
diseas
progress
multifoc
leukoencephalopathi
although
initi
interact
jcv
host
cell
occur
direct
bind
major
viral
capsid
protein
cellsurfac
molecul
possess
sialic
acid
molecul
yet
identifi
order
isol
monoclon
antibodi
inhibit
attach
jcv
establish
immunoscreen
system
use
viruslik
particl
consist
use
system
among
monoclon
antibodi
cell
membran
fraction
jcvpermiss
human
neuroblastoma
cell
isol
monoclon
antibodi
design
specif
inhibit
attach
infect
jcv
cell
antibodi
recogn
singl
molecul
around
kda
molecular
weight
membran
fraction
immunohistochem
stain
demonstr
immunoreact
cell
membran
jcvpermiss
cell
line
glial
cell
human
brain
result
suggest
molecul
recogn
play
role
jcv
infect
might
particip
receptor
coreceptor
jcv
attach
entri
cell
jc
viru
jcv
belong
polyomaviru
famili
nonenvelop
dna
virus
known
caus
agent
progress
multifoc
leukoencephalopathi
pml
demyelin
diseas
central
nervou
system
cn
pml
affect
mainli
immunosuppress
patient
acquir
immunodefici
syndrom
aid
follow
organ
transplant
increas
preval
spread
transplant
aid
howev
still
effect
treatment
pml
major
target
cell
jcv
infect
cn
glial
cell
oligodendrocyt
astrocyt
first
step
establish
jcv
infect
attach
viral
capsid
receptor
host
cell
capsid
jcv
compos
three
capsid
protein
encod
late
region
jcv
major
capsid
protein
form
outer
surfac
virion
report
recombin
deriv
escherichia
coli
insect
cell
form
viruslik
particl
vlp
exhibit
cellular
attach
intracytoplasm
traffick
similar
jcv
virion
addit
report
play
major
function
attach
jcv
cell
antibodi
suppress
viral
entri
cell
subsequ
infect
see
front
matter
elsevi
inc
right
reserv
cellular
receptor
molecul
jcv
unknown
report
nlink
glycoprotein
contain
sialic
acid
base
observ
sialidas
inhibit
infect
glial
cell
jcv
addit
treatment
permiss
cell
tunicamycin
remov
nlink
oligosaccharid
shown
inhibit
jcv
infect
vitro
find
indic
interact
major
structur
protein
sialic
acid
critic
jcv
infect
howev
nonenvelop
virus
unabl
fuse
cell
lipid
membran
bilay
intern
thought
requir
specif
entri
receptor
furthermor
report
infecti
entri
jcv
requir
ligandinduc
signal
inhibit
genistein
proteintyrosin
kinas
inhibitor
mechan
jcv
bind
enter
host
cell
molecul
involv
yet
complet
understood
mous
polyomaviru
pyv
also
known
bind
sialic
acid
residu
yet
identifi
receptor
recent
antibodi
integrin
shown
partial
block
pyv
infect
therefor
integrin
suggest
act
entri
receptor
earli
stage
pyv
infect
fibroblast
antibodi
react
cellsurfac
molecul
import
applic
therapeut
agent
identif
viral
receptor
therefor
attempt
isol
monoclon
antibodi
molecul
jcvpermiss
cell
isol
monoclon
antibodi
cellsurfac
molecul
relat
jcv
infect
permiss
cell
develop
immunoscreen
method
attempt
isol
block
antibodi
jcv
infect
use
immunoscreen
system
isol
monoclon
antibodi
recogn
cellularsurfac
molecul
relat
jcv
infect
antibodi
also
significantli
block
attach
subsequ
infect
jcv
molecul
recogn
antibodi
consid
particip
viru
infect
suggest
molecul
act
viru
receptor
andor
coreceptor
report
success
isol
character
monoclon
antibodi
block
activ
toward
jcv
infect
human
neuroblastoma
cell
line
jcrb
human
embryon
kidney
cell
line
jcrb
human
cervic
carcinoma
cell
line
hela
jcrb
provid
health
scienc
research
resourc
bank
osaka
japan
african
green
monkey
kidney
cell
line
crl
obtain
american
type
cultur
collect
rockvil
md
human
glial
cell
line
svga
kindli
provid
dr
atwood
cell
line
maintain
minim
essenti
medium
dmem
supplement
heatinactiv
fetal
bovin
serum
fb
antibiot
penicillin
streptomycin
sigma
st
loui
mo
co
polyclon
antibodi
antiagnoprotein
antibodi
prepar
describ
previous
known
crossreact
antijcv
tantigen
monoclon
antibodi
purchas
calbiochem
san
diego
ca
antiactin
monoclon
antibodi
purchas
chemicon
temecula
ca
antigfap
polyclon
antibodi
nichirei
tokyo
japan
antisynaptophysin
monoclon
antibodi
dako
japan
polyclon
antibodi
bind
site
birmingham
uk
prepar
commerci
mous
igmisotyp
control
antibodi
obtain
sigma
st
loui
mo
prepar
nativ
jcv
perform
describ
previous
briefli
cell
lysat
jcvproduc
cell
line
jci
cell
harvest
subject
repeat
freezethaw
cycl
treat
mgml
neuraminidas
type
sigma
h
treatment
neuraminidas
sampl
incub
min
centrifug
min
viral
titer
viruscontain
supernat
quantifi
hemagglutin
ha
assay
store
use
prepar
viruslik
particl
vlp
perform
describ
previous
briefli
gene
jcv
subclon
prokaryot
express
vector
novagen
madison
wi
plasmid
transform
e
coli
pli
stratagen
la
jolla
ca
express
induc
mm
isopropylbd
dthiogalactopyranosid
iptg
h
mixtur
centrifug
min
cell
pellet
resuspend
reassoci
buffer
mm
trishcl
ph
mm
nacl
mm
cacl
contain
mgml
lysozym
kept
ice
min
sodium
deoxychol
ad
final
concentr
mgml
min
ice
sampl
lyse
five
cycl
sonic
burst
lysat
treat
dnase
uml
min
centrifug
min
supernat
contain
protein
subject
sucros
cushion
centrifug
h
pellet
resuspend
reassoci
buffer
purifi
cscl
gradient
centrifug
peak
fraction
densiti
gml
collect
dialyz
reassoci
buffer
morpholog
vlp
diamet
nm
confirm
electron
microscopi
vlp
quantifi
ha
assay
describ
previous
cell
harvest
wash
pb
centrifug
min
cell
suspend
volum
solut
contain
sucros
mm
hepe
ph
disrupt
glass
dounc
homogen
nuclei
unbroken
cell
remov
centrifug
min
supernat
transfer
new
centrifug
tube
pellet
h
hitachi
rotor
pellet
resuspend
ml
buffer
contain
sucros
mm
hepe
ph
purifi
sucros
gradient
centrifug
peak
fraction
membran
fraction
collect
centrifug
h
pellet
resuspend
ml
buffer
contain
mm
trishcl
ph
mm
nacl
triton
mm
edta
mm
pmsf
presenc
proteas
inhibitor
lgml
aprotinin
lgml
pepstatin
mm
dtt
incub
min
protein
concentr
quantifi
biorad
hercul
ca
assay
use
bovin
serum
albumin
standard
product
monoclon
antibodi
cellmembran
protein
balbc
mice
immun
five
time
lg
cell
membran
fraction
emulsifi
complet
adjuv
sigma
primari
immun
incomplet
adjuv
sigma
four
immun
interv
dotblot
analysi
enzymelink
immunosorb
assay
elisa
perform
confirm
immunoreact
sera
cell
membran
fraction
mice
show
recognit
cell
membran
fraction
boost
final
immun
day
later
spleen
cell
immun
anim
fuse
myeloma
cell
produc
approxim
hybridomacontain
well
develop
immunoscreen
system
isol
monoclon
antibodi
recogn
jcv
receptor
antibodi
rais
cell
membran
fig
difficult
obtain
suffici
amount
nativ
jcv
use
vlp
instead
nativ
virion
immunoscreen
microtit
plate
nalgen
nunc
intern
rochest
ny
coat
purifi
membran
fraction
lgwell
mm
sodium
bicarbon
buffer
ph
neg
control
well
coat
bsa
left
uncoat
nonspecif
bind
block
pb
ph
contain
block
ace
nan
aliquot
supernat
hybridoma
load
onto
membraneco
well
microtit
plate
incub
overnight
wash
three
time
pb
solut
purifi
vlp
ha
ad
well
follow
incub
h
unbound
vlp
wash
pb
plate
incub
dilut
antibodi
ec
buffer
mm
phosphat
buffer
ph
contain
mm
nacl
mm
edta
block
ace
bsa
nan
chap
room
temperatur
h
wash
pb
dilut
peroxidaseconjug
goat
antirabbit
immunoglobulin
bio
sourc
intern
camarillo
ca
c
buffer
mm
phosphat
buffer
ph
contain
mm
nacl
mm
edta
block
ace
bsa
thimeros
ad
plate
incub
h
room
temperatur
wash
three
time
tmb
reagent
pierc
chemic
rockford
il
ad
develop
min
quench
equal
volum
phosphat
buffer
absorb
measur
nm
micropl
reader
biorad
laboratori
hercul
ca
system
antibodi
recogn
vlp
bind
protein
inhibit
bind
vlp
membraneco
well
antibodi
recogn
vlp
bind
protein
permit
bind
vlp
well
confirm
specif
vlp
bind
well
examin
bind
kinet
initi
determin
much
vlp
appropri
detect
bound
vlp
membraneco
well
amount
vlp
bound
well
increas
dosedepend
manner
hau
reach
satur
concentr
hau
fig
develop
immunoscreen
system
strategi
immunoscreen
system
use
block
antibodi
jcv
infect
balbc
mice
immun
membran
fraction
human
neuroblastoma
cell
line
cell
well
plate
coat
membran
fraction
cell
incub
monoclon
antibodi
deriv
immun
mice
addit
vlp
amount
bound
vlp
membran
fraction
coat
onto
well
quantifi
antibodi
follow
incub
peroxidaseconjug
goat
antirabbit
immunoglobulin
tmb
reagent
absorb
measur
nm
micropl
reader
b
kinet
bind
vlp
membran
fraction
amount
bound
vlp
membran
fraction
increas
dosedepend
manner
peak
presenc
hau
vlp
c
specif
bind
vlp
membraneco
well
bind
vlp
significantli
inhibit
presenc
antibodi
recogn
jcv
viral
capsid
protein
affect
presenc
isotyp
control
rabbit
normal
igg
rb
igg
neg
control
includ
vlp
bsa
membran
bind
well
bar
repres
standard
deviat
mean
least
three
independ
experi
perform
duplic
lg
membran
proteinco
well
fig
addit
rel
low
level
nonspecif
bind
recogn
compar
neg
control
vlp
bind
inhibit
significantli
presenc
antibodi
applic
hau
vlp
fig
thu
demonstr
vlp
bound
membran
specif
manner
immunoscreen
system
immunoscreen
clone
one
clone
design
identifi
one
antibodi
show
greatest
inhibitori
effect
subtyp
shown
igm
use
monoclon
antibodi
isotyp
detect
kit
amershampharmacia
biotech
piscataway
nj
hybridoma
cell
reclon
confirm
product
monospecif
antibodi
cultur
cellin
cultur
system
bd
bioscienc
san
jose
ca
obtain
larg
amount
antibodi
concentr
result
supernat
measur
semiquantit
immunoblot
assay
use
mous
immunoglobulin
standard
antibodi
separ
sdspage
gel
block
skim
milk
pbst
min
antimous
immunoglobulin
dilut
pbst
immunoreact
band
detect
ecl
amershampharmacia
biotech
analyz
plu
imag
analyz
fuji
film
tokyo
japan
concentr
determin
intens
rel
control
antibodi
conjug
purifi
vlp
fluorescein
isothiocyan
fitc
aliquot
mg
purifi
vlp
dissolv
carbonatebicarbon
buffer
ph
mix
lg
fitc
sigma
incub
room
temperatur
h
elimin
unlabel
fitc
sampl
centrifug
h
pellet
dissolv
pb
centrifug
overnight
pellet
resuspend
pb
experi
cell
plate
onto
tissu
cultur
chamber
nalgen
nunc
intern
cultur
dmem
contain
fb
cell
preincub
absenc
presenc
either
lgml
isotyp
control
monoclon
antibodi
h
subsequ
fitcvlp
hau
dilut
dmem
ad
chamber
h
unbound
fitcvlp
remov
wash
pb
incub
min
follow
observ
laser
scan
confoc
microscop
olympu
tokyo
japan
cell
preincub
absenc
presenc
either
lgml
isotyp
control
monoclon
antibodi
h
cell
incub
hau
jcv
fresh
medium
fb
h
wash
twice
fresh
medium
cell
incub
day
dmem
supplement
fb
monolay
cultur
well
wash
pb
lyse
triton
contain
lgml
aprotinin
cell
lysat
centrifug
min
rpm
supernat
separ
sdspage
gel
transfer
separ
protein
onto
pvdf
membran
membran
immers
skim
milktbst
mm
trishcl
ph
mm
nacl
tween
min
subsequ
incub
either
antiagnoprotein
antibodi
antitantigen
antibodi
dilut
tbst
h
wash
twice
tbst
membran
incub
hrpconjug
f
ab
goat
antirabbit
hrpconjug
f
ab
goat
antimous
immunoglobulin
dilut
tbst
h
immunoreact
band
detect
use
ecl
reagent
amershampharmacia
biotech
analyz
use
plu
imag
analyz
express
viral
protein
cell
repres
intens
rel
control
sampl
without
treatment
isotyp
control
antibodi
data
present
mean
valu
sd
three
independ
experi
immunoblot
immunoblot
perform
describ
follow
modif
purifi
membran
fraction
separ
sdspage
gel
transfer
onto
pvdf
membran
immunoblot
antibodi
immunoreact
band
analyz
describ
immunocytochemistri
cell
grown
chamber
fix
methanol
min
rehydr
pb
min
room
temperatur
incub
block
solut
pb
contain
bsa
cell
incub
antibodi
dilut
block
solut
h
wash
three
time
pb
cell
incub
alexa
fluor
goat
antimous
igm
antibodi
molecular
probe
eugen
dilut
h
observ
use
laser
scan
confoc
microscop
olympu
immunohistochemistri
normal
human
brain
tissu
obtain
autopsi
section
thick
lm
cryo
cryostat
sankyo
tokyo
japan
fix
aceton
min
section
rins
pb
block
h
methanol
min
incub
overnight
incub
biotinyl
second
antibodi
immunoreact
product
visual
diaminobenzidin
doubl
immunostain
human
brain
tissu
section
rins
twice
pb
preincub
pb
contain
bsa
min
incub
antigli
fibrillari
acid
protein
gfap
dilut
anticarbon
anhydraseii
dilut
antisynaptophysin
dilut
togeth
overnight
section
incub
appropri
secondari
antibodi
includ
alexa
fluor
goat
antirabbit
igg
biotinyl
antisheep
igg
alexa
fluor
streptavidin
alexa
fluor
goat
antimous
igg
alexa
fluor
goat
antimous
igm
molecular
probe
rins
pb
min
section
observ
laser
scan
confoc
microscopi
among
clone
monoclon
antibodi
cell
membran
fraction
jcvpermiss
human
neuroblastoma
cell
line
cell
one
hybridoma
clone
isol
use
immunoscreen
system
design
fig
significantli
inhibit
bind
vlp
fig
well
jcv
fig
cell
membran
fraction
immunopl
wherea
isotyp
control
antibodi
mous
igm
show
inhibitori
effect
fig
b
evalu
inhibitori
effect
attach
entri
vlp
function
cellular
attach
entri
similar
nativ
jcv
infect
cell
cell
pretreat
presenc
either
isotyp
control
monoclon
antibodi
incub
fitclabel
vlp
complet
inhibit
cellular
attach
entri
fitcvlp
cell
isotyp
control
antibodi
effect
attach
entri
fig
determin
block
activ
jcv
infect
cell
incub
jcv
inocul
four
day
inocul
express
viral
protein
includ
earli
late
viral
protein
tantigen
agnoprotein
examin
immunoblot
treatment
markedli
inhibit
express
tantigen
agnoprotein
jcvinfect
cell
fig
b
inhibitori
effect
jcv
infect
dosedepend
fig
thu
demonstr
possess
inhibit
activ
jcv
infect
suggest
molecul
recogn
play
role
cellular
receptor
jcv
character
molecul
recogn
immunoblot
clearli
recogn
singl
band
molecular
weight
around
kda
membran
fraction
cell
fig
immunoblot
also
perform
use
variou
cell
line
includ
hela
svga
cell
recogn
singl
band
molecular
weight
cell
howev
hela
svga
cell
posit
signal
observ
around
kda
instead
kda
fig
next
investig
subcellular
local
posit
signal
cell
immunocytochemistri
immunoposit
signal
detect
mainli
cell
surfac
intracytoplasm
compart
fig
perform
immunocytochem
examin
use
hela
co
svg
cell
cell
immunoposit
signal
also
recogn
cell
surfac
cytoplasm
data
shown
recent
report
jcv
receptortyp
sialic
acid
local
oligodendrocyt
astrocyt
cortic
neuron
although
viral
genom
detect
variou
organ
kidney
lymphoid
tissu
lung
liver
intestin
tract
major
target
cell
jcv
infect
cn
glial
cell
oligodendrocyt
astrocyt
therefor
investig
subcellular
local
molecul
recogn
human
brain
posit
signal
distribut
glial
cell
cerebrum
cerebellum
fig
confirm
cellular
distribut
immunoposit
signal
perform
doubl
immunofluoresc
stain
use
cellspecif
marker
marker
oligodendrocyt
gfap
marker
astrocyt
synaptophysin
neuron
marker
gi
fig
immunoposit
signal
coloc
gfap
fig
howev
fail
react
synaptophysinposit
neuron
fig
result
indic
molecul
recogn
distribut
mainli
glial
cell
human
brain
viru
attach
cellsurfac
molecul
initi
event
process
viru
infect
mani
virus
util
variou
receptor
attach
entri
cell
polyomaviru
simian
vacuol
viru
sv
bind
mhc
class
molecul
cell
surfac
mhc
molecul
intern
cell
togeth
sv
gangliosid
also
bind
sv
mediat
transport
viru
plasma
membran
endoplasm
reticulum
er
role
function
receptor
suggest
mous
polyomaviru
pyv
also
known
bind
sialic
acid
yet
unidentifi
receptor
effort
identifi
receptor
screen
monoclon
antibodi
protect
cell
infect
unsuccess
report
antibodi
integrin
partial
inhibit
pyv
infect
therefor
integrin
suggest
act
entri
receptor
earli
stage
pyv
infect
fibroblast
pyv
util
gangliosid
carrier
plasma
membran
er
interestingli
pyv
shown
use
clathrinindepend
caveolin
depend
mechan
infect
cell
respect
contrast
jcv
enter
host
cell
receptormedi
clathrindepend
endocytosi
furthermor
report
jcv
share
receptor
specif
sv
human
glial
cell
anticlass
antibodi
fail
inhibit
jcv
infect
report
sialic
acidcontain
glycoprotein
one
receptor
human
polyomaviru
jcv
human
glial
cell
neuraminidas
treatment
suppress
jcv
attach
cell
subsequ
infect
present
studi
shown
monoclon
antibodi
inhibit
jcv
infect
cell
although
major
target
jcv
infect
central
nervou
system
glial
cell
viral
genom
detect
variou
organ
kidney
lymphoid
tissu
lung
liver
gastrointestin
tract
jcv
enter
wide
varieti
cell
type
molecul
recogn
detect
cell
also
cell
line
includ
human
kidney
cell
line
addit
show
inhibit
cellular
attach
entri
fitcvlp
cell
data
shown
result
suggest
molecul
recogn
also
act
receptor
cell
fail
complet
inhibit
infect
addit
molecul
might
particip
jcv
attach
infect
interest
note
jcv
suggest
persist
infect
kidney
jcv
genom
detect
urin
renal
tissu
healthi
individu
also
recogn
molecul
kda
membran
fraction
hela
svga
cell
smaller
molecul
might
isotyp
proteolyt
product
larger
molecul
report
monoclon
antibodi
hyaluronan
receptor
recogn
two
distinct
receptor
cell
membran
rat
liver
sinusoid
endotheli
cell
identifi
previous
hyaluronanbind
protein
kda
reduct
disulfid
bond
hyaluronan
receptor
shown
singl
protein
wherea
molecul
consist
three
subunit
ie
kda
b
kda
c
subunit
kda
report
receptor
deriv
receptor
proteolyt
process
similar
hyaluronan
receptor
molecul
kda
recogn
might
isoreceptor
ligand
product
deriv
larger
receptor
complex
report
receptor
molecular
weight
human
coronaviru
isol
newborn
mous
brain
membran
fraction
molecul
detect
hela
svg
cell
might
similar
coronaviru
receptor
also
examin
local
put
receptor
molecul
human
brain
jcv
infect
mainli
glial
cell
central
nervou
system
posit
immunoreact
coloc
oligodendrocyt
gfapposit
astrocyt
fail
coloc
synaptophysinposit
neuron
find
indic
put
receptor
molecul
jcv
local
mainli
glial
cell
human
brain
present
studi
neuroblastoma
cell
line
use
immunogen
monoclon
antibodi
cell
highli
suscept
jcv
infect
furthermor
immun
cell
shown
produc
antibodi
specif
recogn
molecul
oligodendrocyt
thu
suggest
cell
possess
molecul
common
brain
glial
cell
fig
b
immunoposit
signal
less
fig
g
suppos
differ
oligodendrocyt
immunostain
pattern
among
fig
b
might
due
appli
immunostain
system
fig
appli
biotinyl
antibodi
second
antibodi
section
observ
light
microscopi
meanwhil
fig
observ
section
label
alexa
fluor
second
antibodi
fluoresc
microscopi
summari
isol
monoclon
antibodi
receptor
molecul
jcv
newli
establish
immunoscreen
system
isol
monoclon
antibodi
inhibit
cellular
attach
fig
subcellular
local
molecul
recogn
human
brain
immunoreact
cerebrum
cerebellum
b
arrow
indic
immunoposit
cell
b
white
matter
scale
bar
lm
b
doubl
immunostain
use
antibodi
ac
antigfap
antibodi
df
antisynaptophysin
antibodi
gi
cerebrum
merg
imag
show
molecul
recogn
red
color
coloc
gfap
green
color
howev
coloc
detect
antisynaptophysin
signal
arrow
indic
posit
cell
ac
asterisk
indic
white
matter
gi
scale
bar
lm
infect
jcv
also
show
antibodi
specif
recogn
membran
molecul
molecular
weight
kda
posit
signal
observ
glial
cell
human
brain
result
suggest
molecul
recogn
act
jcv
receptor
jcv
infect
studi
requir
character
determin
function
role
molecul
greater
understand
molecular
characterist
receptor
molecul
necessari
design
novel
antijcv
agent
experi
identifi
molecul
detect
use
k
phage
librari
current
progress
laboratori
recent
report
antagonist
antibodi
serotonerg
receptor
block
jcv
infect
svga
cell
suggest
serotonin
receptor
act
one
jcv
receptor
